TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY

Mostrar otras versiones (1)

BACKGROUND. SARS-CoV-2 causes COVID-19 through direct lysis of infected lung epithelial cells, which releases damage-associated molecular patterns (DAMPs) and induces a pro-inflammatory cytokine milieu causing systemic inflammation. Anti-viral and anti-inflammatory agents have shown limited therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, No-Joon, Allen, Carter, Vilgelm, Anna E., Riesenberg, Brian P., Weller, Kevin P., Reynolds, Kelsi, Chakravarthy, Karthik B., Kumar, Amrendra, Khatiwada, Aastha, Sun, Zequn, Ma, Anjun, Chang, Yuzhou, Yusuf, Mohamed, Li, Anqi, Zeng, Cong, Evans, John P., Bucci, Donna, Gunasena, Manuja, Xu, Menglin, Liyanage, Namal P.M., Bolyard, Chelsea, Velegraki, Maria, Liu, Shan-Lu, Ma, Qin, Devenport, Martin, Liu, Yang, Zheng, Pan, Malvestutto, Carlos D., Chung, Dongjun, Li, Zihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404902/
https://www.ncbi.nlm.nih.gov/pubmed/34462760
http://dx.doi.org/10.1101/2021.08.18.21262258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404902/
https://www.ncbi.nlm.nih.gov/pubmed/34462760
http://dx.doi.org/10.1101/2021.08.18.21262258

Ejemplares similares